维普期刊资源整合服务平台（V6.5）

44篇 您的检索式：作者名="Sobrero AF"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Phase Ⅱ study of NGR-hTNF,a selective vascular targeting agent,in patients with metastatic colorectal cancer after failure of standard therapy显示文摘	Santoro A Rimassa L Sobrero AF	2010	Eur J Cancer2010，46，15：	1
2	EPIC: Phase Ⅲ trial of cetuximab plus irinotecan after fluoropyfimidine and oxaliplatin failure in patients with metastatic eolorectal cancer 显示文摘	Sobrero AF Maurel J Fehmnbacher L	2008	J Clin Oncol2008，26，14：	1
3	Fluorouracil in colorectal cancer-- a tale of two drugs: implications for biochemical modulation显示文摘	Sobrero AF Aschele C Bertino JR	1997	J Clin Oncol1997，15，1：	1
4	Schedule - dependent synergism between raltitrexed and irinotecan in human colon cancer cells in vitro 显示文摘	Aschele C Baldo C Sobrero AF	1998	Clin Cancer Res1998，4，5：	1
5	Fluorouracil in colorectal cancer-a tale of two drugs: implications for biochemical modulation 显示文摘	Sobrero AF Aschele C Bertino JR	1997	J Clin Oncol1997，15，1：	1
6	Taxane-induced nail chan- ges : incidence, clinical presentation and outcome 显示文摘	Minisini AM Tosti A Sobrero AF	2003	Annals of On- cology2003，14，：	1
7	EPIC: phase Ⅲ trial of cetuximab plus irinotecan after fluorepyrlmidine and oxaliplatin failure in patients with metastatic colorectal cancer显示文摘	Sobrero AF Manrel J Fehrenbacher L	2008	J Clin Oncol2008，26，14：	1
8	EPIC: Phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxali- platin failure in patients with metastatic colorectal cancer 显示文摘	Sobrero AF Maurel J Fehrenbacher L	2008	J Clin Oncol2008，26，14：	1
9	EPIC : phase Ⅲ trim of cetux- imab plus irinoteean after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer 显示文摘	Sobrero AF Maurel J Fehrenbaeher L	2012	Clin One012012，26，12：	1
10	Phase Ⅳ study of first - line bevacizumab plus irinotecan and infusional 5-FU/LV in patients with metastatic colorectal cancer: AVIRI 显示文摘	Sobrero AF Young S Balcewicz M	2007	J Clin Oncol2007，25，18：	1
11	EPIC:phase Ⅲ trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer显示文摘	Sobrero AF Maurel J Fehrenbacher L	2008	J Clin Oncol2008，26，14：	1
12	EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer 显示文摘	Sobrero AF Maurel J Fehrenbacher L	2008	J Clin Oncol2008，26，14：	1
13	Schedule-dependent synergism between raltitrexed and irinotecan in human colon cancer cells in vitro显示文摘	Aschele C Baldo C Sobrero AF	1998	Clin Cancer Res JT1998，4，5：	1
14	Schedule-dependent synergism between raltitrexed and irinotecan in human colon cancer cells in vitro显示文摘	Aschele C Baldo C Sobrero AF	1998	Clin Cancer Res1998，4，5：	1
15	Phase III CORRECT trial of regorafenib in metastatic colorectal cancer (mCRC)显示文摘	Van Cutsem E Sobrero AF Siena S		0，，3502：	1
16	Fluorouracil in colorectal cancer-a tale of two drugs: implications for biochemical modulation显示文摘	Sobrero AF Aschele C Bertine JR	1997	J Clin Oncol1997，15，1：	1
17	EPIC:phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer显示文摘	Sobrero AF Maurel J Fehrenbacher L	2008	Journal of Clinical Oncology2008，26，14：	1
18	Final results from study 181:Randomized phase III study of FOLFIRI with or without panitumumab(pmab)for the treatment of second-line metastatic colorectal cancer(mCRC)显示文摘	Sobrero AF Peeters M Price TJ	2012	ASCO Meeting Abstracts2012，30，4：	1
19	Phase II study of NGR-hT-NF,a selective vascular targeting agent,in patients with metastaticcolorectal cancer after failure of standard therapy显示文摘	Santoro A Rimassa L Sobrero AF	2010	Eur J Cancer2010，46，15：	1
20	EPIC:phase Ⅲ trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer显示文摘	Sobrero AF Maurel J Fehrenbacher L	2008	J Clin Oncol2008，26，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示